Terwey T

GH Research PLC , Chief Executive Officer, ,

1 paper

A Phase 1, Dose-Ranging Study to Assess Safety and Psychoactive Effects of a Vaporized 5-Methoxy-N,N-Dimethyltryptamine Formulation (GH001) in Healthy Volunteers

Reckweg J, Mason N, Van Leeuwen C +3